• レポートコード:GIR-22E7888 • 出版社/出版日:GlobalInfoResearch / 2022年5月 • レポート形態:英文、PDF、94ページ • 納品方法:Eメール(2~3営業日) • 産業分類:医療機器 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
生命科学用ウシ胎児血清市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の生命科学用ウシ胎児血清の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。 生命科学用ウシ胎児血清市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・北米産、南米産、オーストラリア産、その他 用途別セグメントは次のように区分されます。 ・科学研究、工業生産 世界の生命科学用ウシ胎児血清市場の主要な市場プレーヤーは以下のとおりです。 ・Thermo Fisher、GE Healthcare、Merck、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest 地域別セグメントは次の地域・国をカバーします。 ・北米(米国、カナダ、メキシコ) ・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア) ・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア) ・南アメリカ(ブラジル、アルゼンチン、コロンビア) ・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ) 本調査レポートの内容は計15章あります。 ・第1章では、生命科学用ウシ胎児血清製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な生命科学用ウシ胎児血清メーカーの企業概要、2019年~2022年までの生命科学用ウシ胎児血清の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な生命科学用ウシ胎児血清メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年~2028年までの地域別生命科学用ウシ胎児血清の販売量、売上、成長性を示しています。 ・第5、6章では、2017年~2028年までの生命科学用ウシ胎児血清の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での生命科学用ウシ胎児血清市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および生命科学用ウシ胎児血清の産業チェーンを掲載しています。 ・第13、14、15章では、生命科学用ウシ胎児血清の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報(企業概要、製品概要、販売量、価格、売上):Thermo Fisher、GE Healthcare、Merck、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年:北米産、南米産、オーストラリア産、その他 ・用途別分析2017年-2028年:科学研究、工業生産 ・生命科学用ウシ胎児血清の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ ・生命科学用ウシ胎児血清のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア ・生命科学用ウシ胎児血清のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア ・生命科学用ウシ胎児血清の南米市場規模2017年-2028年:ブラジル、アルゼンチン ・生命科学用ウシ胎児血清の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fetal Bovine Serum for Life Sciences market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fetal Bovine Serum for Life Sciences market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Scientific Research accounting for % of the Fetal Bovine Serum for Life Sciences global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While North America-sourced segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fetal Bovine Serum for Life Sciences include Thermo Fisher, GE Healthcare, Merck, Moregate BioTech, and Gemini, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fetal Bovine Serum for Life Sciences market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
North America-sourced
South America-sourced
Australia-sourced
Others
Market segment by Application can be divided into
Scientific Research
Industrial Production
The key market players for global Fetal Bovine Serum for Life Sciences market are listed below:
Thermo Fisher
GE Healthcare
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fetal Bovine Serum for Life Sciences product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fetal Bovine Serum for Life Sciences, with price, sales, revenue and global market share of Fetal Bovine Serum for Life Sciences from 2019 to 2022.
Chapter 3, the Fetal Bovine Serum for Life Sciences competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fetal Bovine Serum for Life Sciences breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fetal Bovine Serum for Life Sciences market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fetal Bovine Serum for Life Sciences.
Chapter 13, 14, and 15, to describe Fetal Bovine Serum for Life Sciences sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Fetal Bovine Serum for Life Sciences Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fetal Bovine Serum for Life Sciences Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 North America-sourced
1.2.3 South America-sourced
1.2.4 Australia-sourced
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Fetal Bovine Serum for Life Sciences Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Global Fetal Bovine Serum for Life Sciences Market Size & Forecast
1.4.1 Global Fetal Bovine Serum for Life Sciences Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fetal Bovine Serum for Life Sciences Sales in Volume (2017-2028)
1.4.3 Global Fetal Bovine Serum for Life Sciences Price (2017-2028)
1.5 Global Fetal Bovine Serum for Life Sciences Production Capacity Analysis
1.5.1 Global Fetal Bovine Serum for Life Sciences Total Production Capacity (2017-2028)
1.5.2 Global Fetal Bovine Serum for Life Sciences Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fetal Bovine Serum for Life Sciences Market Drivers
1.6.2 Fetal Bovine Serum for Life Sciences Market Restraints
1.6.3 Fetal Bovine Serum for Life Sciences Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Fetal Bovine Serum for Life Sciences Product and Services
2.1.4 Thermo Fisher Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Fetal Bovine Serum for Life Sciences Product and Services
2.2.4 GE Healthcare Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Fetal Bovine Serum for Life Sciences Product and Services
2.3.4 Merck Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Moregate BioTech
2.4.1 Moregate BioTech Details
2.4.2 Moregate BioTech Major Business
2.4.3 Moregate BioTech Fetal Bovine Serum for Life Sciences Product and Services
2.4.4 Moregate BioTech Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Gemini
2.5.1 Gemini Details
2.5.2 Gemini Major Business
2.5.3 Gemini Fetal Bovine Serum for Life Sciences Product and Services
2.5.4 Gemini Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Atlanta Biologicals
2.6.1 Atlanta Biologicals Details
2.6.2 Atlanta Biologicals Major Business
2.6.3 Atlanta Biologicals Fetal Bovine Serum for Life Sciences Product and Services
2.6.4 Atlanta Biologicals Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Tissue Culture Biologicals
2.7.1 Tissue Culture Biologicals Details
2.7.2 Tissue Culture Biologicals Major Business
2.7.3 Tissue Culture Biologicals Fetal Bovine Serum for Life Sciences Product and Services
2.7.4 Tissue Culture Biologicals Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bovogen
2.8.1 Bovogen Details
2.8.2 Bovogen Major Business
2.8.3 Bovogen Fetal Bovine Serum for Life Sciences Product and Services
2.8.4 Bovogen Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biowest
2.9.1 Biowest Details
2.9.2 Biowest Major Business
2.9.3 Biowest Fetal Bovine Serum for Life Sciences Product and Services
2.9.4 Biowest Fetal Bovine Serum for Life Sciences Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fetal Bovine Serum for Life Sciences Breakdown Data by Manufacturer
3.1 Global Fetal Bovine Serum for Life Sciences Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fetal Bovine Serum for Life Sciences Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fetal Bovine Serum for Life Sciences
3.4 Market Concentration Rate
3.4.1 Top 3 Fetal Bovine Serum for Life Sciences Manufacturer Market Share in 2021
3.4.2 Top 6 Fetal Bovine Serum for Life Sciences Manufacturer Market Share in 2021
3.5 Global Fetal Bovine Serum for Life Sciences Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fetal Bovine Serum for Life Sciences Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fetal Bovine Serum for Life Sciences Market Size by Region
4.1.1 Global Fetal Bovine Serum for Life Sciences Sales in Volume by Region (2017-2028)
4.1.2 Global Fetal Bovine Serum for Life Sciences Revenue by Region (2017-2028)
4.2 North America Fetal Bovine Serum for Life Sciences Revenue (2017-2028)
4.3 Europe Fetal Bovine Serum for Life Sciences Revenue (2017-2028)
4.4 Asia-Pacific Fetal Bovine Serum for Life Sciences Revenue (2017-2028)
4.5 South America Fetal Bovine Serum for Life Sciences Revenue (2017-2028)
4.6 Middle East and Africa Fetal Bovine Serum for Life Sciences Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fetal Bovine Serum for Life Sciences Sales in Volume by Type (2017-2028)
5.2 Global Fetal Bovine Serum for Life Sciences Revenue by Type (2017-2028)
5.3 Global Fetal Bovine Serum for Life Sciences Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fetal Bovine Serum for Life Sciences Sales in Volume by Application (2017-2028)
6.2 Global Fetal Bovine Serum for Life Sciences Revenue by Application (2017-2028)
6.3 Global Fetal Bovine Serum for Life Sciences Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fetal Bovine Serum for Life Sciences Sales by Type (2017-2028)
7.2 North America Fetal Bovine Serum for Life Sciences Sales by Application (2017-2028)
7.3 North America Fetal Bovine Serum for Life Sciences Market Size by Country
7.3.1 North America Fetal Bovine Serum for Life Sciences Sales in Volume by Country (2017-2028)
7.3.2 North America Fetal Bovine Serum for Life Sciences Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fetal Bovine Serum for Life Sciences Sales by Type (2017-2028)
8.2 Europe Fetal Bovine Serum for Life Sciences Sales by Application (2017-2028)
8.3 Europe Fetal Bovine Serum for Life Sciences Market Size by Country
8.3.1 Europe Fetal Bovine Serum for Life Sciences Sales in Volume by Country (2017-2028)
8.3.2 Europe Fetal Bovine Serum for Life Sciences Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fetal Bovine Serum for Life Sciences Sales by Type (2017-2028)
9.2 Asia-Pacific Fetal Bovine Serum for Life Sciences Sales by Application (2017-2028)
9.3 Asia-Pacific Fetal Bovine Serum for Life Sciences Market Size by Region
9.3.1 Asia-Pacific Fetal Bovine Serum for Life Sciences Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fetal Bovine Serum for Life Sciences Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fetal Bovine Serum for Life Sciences Sales by Type (2017-2028)
10.2 South America Fetal Bovine Serum for Life Sciences Sales by Application (2017-2028)
10.3 South America Fetal Bovine Serum for Life Sciences Market Size by Country
10.3.1 South America Fetal Bovine Serum for Life Sciences Sales in Volume by Country (2017-2028)
10.3.2 South America Fetal Bovine Serum for Life Sciences Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fetal Bovine Serum for Life Sciences Sales by Type (2017-2028)
11.2 Middle East & Africa Fetal Bovine Serum for Life Sciences Sales by Application (2017-2028)
11.3 Middle East & Africa Fetal Bovine Serum for Life Sciences Market Size by Country
11.3.1 Middle East & Africa Fetal Bovine Serum for Life Sciences Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fetal Bovine Serum for Life Sciences Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fetal Bovine Serum for Life Sciences and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fetal Bovine Serum for Life Sciences
12.3 Fetal Bovine Serum for Life Sciences Production Process
12.4 Fetal Bovine Serum for Life Sciences Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fetal Bovine Serum for Life Sciences Typical Distributors
13.3 Fetal Bovine Serum for Life Sciences Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer